Medical Cannabis Pay Stock Annual Yield
| REFG Stock | USD 0.0001 0.00 0.00% |
Medical Cannabis Pay fundamentals help investors to digest information that contributes to Medical Cannabis' financial success or failures. It also enables traders to predict the movement of Medical Pink Sheet. The fundamental analysis module provides a way to measure Medical Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medical Cannabis pink sheet.
Medical |
Medical Cannabis Pay Company Annual Yield Analysis
Medical Cannabis' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Medical Cannabis Pay has an Annual Yield of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Health Information Services (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Medical Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medical Cannabis' direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medical Cannabis could also be used in its relative valuation, which is a method of valuing Medical Cannabis by comparing valuation metrics of similar companies.Medical Cannabis is currently under evaluation in annual yield category among its peers.
Medical Fundamentals
| Return On Asset | -42.59 | |||
| Current Valuation | 4.53 M | |||
| Price To Earning | (10.30) X | |||
| EBITDA | (4.19 M) | |||
| Net Income | (4.25 M) | |||
| Cash And Equivalents | 27.7 K | |||
| Total Debt | 230.35 K | |||
| Current Ratio | 0.09 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (302.56 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 1.55 | |||
| Market Capitalization | 1.4 M | |||
| Total Asset | 52.7 K | |||
| Retained Earnings | (975 K) | |||
| Working Capital | (114 K) | |||
| Current Asset | 56 K | |||
| Current Liabilities | 170 K | |||
| Net Asset | 52.7 K |
About Medical Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medical Cannabis Pay's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Cannabis Pay based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Medical Pink Sheet
Medical Cannabis financial ratios help investors to determine whether Medical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medical with respect to the benefits of owning Medical Cannabis security.